www.medpagetoday.com - 10/1/12
VIENNA (MedPage Today) -- An investigational androgen receptor antagonist achieved partial response or stable disease after 12 weeks of therapy in almost all evaluable patients with castration-resistant prostate cancer, an initial clinical study showed.
www.medpagetoday.com - 9/26/12
(MedPage Today) -- A suite of 12 genetic variations may help doctors determine who will have erectile dysfunction after radiation therapy for prostate cancer, researchers reported.
www.medpagetoday.com - 9/25/12
(MedPage Today) -- MRI evaluation of clinically low-risk prostate cancer demonstrated high accuracy for predicting disease status in men evaluated for watchful waiting, data from a prospective clinical study showed.
www.medpagetoday.com - 9/16/12
(MedPage Today) -- Final results of a phase III trial confirm that treatment with abiraterone prolongs overall survival in advanced prostate cancer that has progressed after docetaxel therapy.
www.medpagetoday.com - 7/29/12
(MedPage Today) -- Elimination of PSA testing would triple the number of men who have advanced prostate cancer at diagnosis, authors of a retrospective review concluded.